Top compounds associated with response to CHRD


Feature Type Standardized
Nominal ANOVA
mRNA pluripotin CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA Docetaxel gCSI pan-cancer AAC -0.21 7e-05
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.14 8e-05
mRNA paclitaxel gCSI pan-cancer AAC -0.2 0.0001
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.001
mRNA BRD-K13185470 CTRPv2 pan-cancer AAC 0.21 0.001
mRNA lovastatin CTRPv2 pan-cancer AAC -0.11 0.002
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.11 0.003
Download CSV